ocal drug delivery in patients suffering from chronic periodontitis using sodium cromoglycate fibres
- Conditions
- Health Condition 1: Z533- Procedure converted to open procedure
- Registration Number
- CTRI/2019/10/021590
- Lead Sponsor
- Sharda University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Willingness to comply with the study protocol.
2 Subjects in the age group >=30 years without any systemic disease.
3 >=20 teeth present in the oral cavity.
4 Patients with moderate chronic periodontitis having >=2 interproximal sites, with
Clinical Attachment Loss (CAL) >=4mm (not on the same tooth) and interproximal
sites with Probing Pocket Depth (PPD) >=5mm, also (not on the same tooth) each
tooth site in two different quadrants.
1 Patient with any systemic disease.
2 Patient with aggressive periodontitis.
3 Users of tobacco in any form.
4 Patient on systemic mast cell stabilizer therapy.
5 Patient who had undergone periodontal therapy in previous 6 months.
6 Individual with known or suspected allergy to mast cell stabilizer group.
7 Pregnant or lactating women.
8 Patient with history of Antibiotic therapy for any chronic inflammatory condition
within 6 months prior to study.
9 Patient not willing to give written consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method